Medgenics Receives FDA Clearance To Commence Phase IIb Trial Of EPODURE For ... - TheStreet.com (press release) PDF Print
TheStreet.com (press release)
Treatment of anemia in dialysis patients with EPODURE is intended to replace frequent injections of EPO or other erythropoietic stimulating agents (“ESAs”). These ETFs hold-up well when the stock market tanks. By Michael Johnston New JCP CEO Ron

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.